LON:SENS

Sensyne Health (SENS) Share Price, News & Analysis

GBX 0.35
-0.18 (-33.33%)
(As of 06/17/2022)
Today's Range
0.16
0.60
50-Day Range
0.35
0.35
52-Week Range
0.16
155
Volume
4.45 million shs
Average Volume
3.45 million shs
Market Capitalization
£582,624.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SENS stock logo

About Sensyne Health Stock (LON:SENS)

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.

SENS Stock Price History

SENS Stock News Headlines

Do NOT read if you believe in “woke” politics
I have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.
Are Health Insurance Premiums Tax-Deductible?
Find The Right Health Insurance For You
Do NOT read if you believe in “woke” politics
I have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.
In the year business leaders lost it, the winner is
Snow takes over as Sensyne ditches sale
Form 8.3 - Lupus alpha Asset Management AG: Sensyne Health PLC
See More Headlines
Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£7.81 million
Cash Flow
GBX 4.90 per share
Book Value
GBX 20.30 per share

Miscellaneous

Free Float
N/A
Market Cap
£582,624.00
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

SENS Stock Analysis - Frequently Asked Questions

How have SENS shares performed in 2024?

Sensyne Health's stock was trading at GBX 0.35 at the start of the year. Since then, SENS stock has increased by 0.0% and is now trading at GBX 0.35.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Sensyne Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensyne Health investors own include Fresenius Medical Care (FME), Green Plains Partners (GPP), Hershey (HSY), Gilead Sciences (GILD), Griffon (GFF), Emerald (EEX), DHX Media (DHXM), Ctrip.Com International (CTRP), Corus Entertainment (CJR) and Citizens Financial Group (CFG).

How do I buy shares of Sensyne Health?

Shares of SENS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SENS) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners